您的位置: 主页 > 动态 > 公司动态 >

葛兰素史克总公司向中国人民的致歉声明

本文摘要:FollowingacomprehensiveinvestigationbytheChinesejudicialauthorities,GSKChinaInvestmentCo.Ltd(GSKCI)hasbeenidentifiedaccordingtoChineselawtohaveofferedmoneyorpropertytonon-governmentpersonnelinordertoobtainimpropercommercialgains,andhasbeen

app最新下载

FollowingacomprehensiveinvestigationbytheChinesejudicialauthorities,GSKChinaInvestmentCo.Ltd(GSKCI)hasbeenidentifiedaccordingtoChineselawtohaveofferedmoneyorpropertytonon-governmentpersonnelinordertoobtainimpropercommercialgains,andhasbeenfoundguiltyofbribingnon-governmentpersonnel.GSKplcfullyacceptsthefactsandevidenceoftheinvestigation,andtheverdictoftheChinesejudicialauthorities.Furthermore,GSKplcsincerelyapologisestotheChinesepatients,doctorsandhospitals,andtotheChineseGovernmentandtheChinesepeople.GSKplcdeeplyregretsthedamagecaused.GSKplcalsoapologisesfortheharmcausedtoindividualswhowereillegallyinvestigatedbyGSKCI.TheillegalactivitiesofGSKCIareaclearbreachofGSKplc’sgovernanceandcomplianceprocedures;andarewhollycontrarytoth

乐鱼体育平台

evaluesandstandardsweexpectfromouremployees.Itisdeeplydisappointingthattheseissueswerenotidentifiedandaddressed.GSKplchasreflecteddeeplyandlearnedfromitsmistakes,hastakenstepstocomprehensivelyrectifytheissuesidentifiedattheoperationsofGSKCI,andmustworkhardtoregainthetrustoftheChinesepeople.Today,GSKplcmakesafurthercommitmenttotheChinesegovernmentandpeoplethatGSKCIwilltaketangibleactionstoestablishitselfasamodelforreforminChina’shealthcareindustry:bycontinuingtoinvestinChinaandsupportingChinasscientificdevelopment;andbyfurtherdevelopmentofinnovativenewmedicinesandvaccinesfordiseasesprevalentinChina.GSKCIwillalsoincreaseaccesstoitsproductsinbothcityandruralareasofChinathroughgreaterexpansionofproductionandthroughpriceflexibility.
本文关键词:葛兰,素,史克,总公司,向,app最新下载,中国人民,的,致歉

本文来源:乐鱼体育平台-www.endurancecvmed.com